Credo Reference (United States)
- World rank, all time
- #41,430 of 42,892
- Rank in United States
- #8,543 of 8,685
- Research works
- 143 ▲ 67% vs 2013–17
- Citations
- 734 5.1 per fractional work
- Top-10% rate
- 9.5% record average 16.5%
- Open access
- 76% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Decision Sciences, 3.5×. Every wedge is a field page.
- Decision Sciences 3.5×
- Medicine 3.3×
- Dentistry 1.9×
- Immunology and Microbiology 1.8×
- Biochemistry, Genetics and Molecular Biology 1.4×
- Nursing 1.4×
- Neuroscience 1.2×
- Economics, Econometrics and Finance 0.9×
- Pharmacology, Toxicology and Pharmaceutics 0.8×
- Business, Management and Accounting 0.7×
- Physics and Astronomy 0.5×
- Social Sciences 0.5×
- Environmental Science 0.5×
- Health Professions 0.4×
- Psychology 0.2×
- Arts and Humanities 0.2×
- Earth and Planetary Sciences 0.2×
- Agricultural and Biological Sciences 0.1×
- Engineering 0.1×
- Computer Science 0.1×
Which keywords describe research at Credo Reference (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Treatment, Clinical Trials, Regenerative Medicine, Stock Market Prediction, Time Series Forecasting, Management and Diagnosis.
- Time Series Forecasting
- Regenerative Medicine
- Diagnosis
- Clinical Trials
- Treatment
- Epidemiology
- Deep Learning
- Management
- Inflammation
- Stock Market Prediction
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 10 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 10 words, with their numbers
- Epidemiology3▲ 2.5×28 topics
- Treatment2▲ 4.9×18 topics
- Deep Learning1▲ 1.21×4 topics
- Clinical Trials1▲ 6.1×10 topics
- Management1▲ 5.0×11 topics
- Diagnosis1▲ 3.8×14 topics
- Inflammation1▲ 1.73×15 topics
- Regenerative Medicine1▲ 14×3 topics
- Stock Market Prediction1▲ 59×1 topic
- Time Series Forecasting1▲ 59×1 topic
Which research topics does Credo Reference (United States) publish most on?
By volume in 2022–2025: Stock Market Forecasting Methods, Spine and Intervertebral Disc Pathology, Coronary Interventions and Diagnostics and Spinal Fractures and Fixation Techniques.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Stock Market Forecasting Methods Management Science and Operations Research 1 works
- 2 Spine and Intervertebral Disc Pathology Pathology and Forensic Medicine 1 works
- 3 Coronary Interventions and Diagnostics Surgery 0 works
- 4 Spinal Fractures and Fixation Techniques Surgery 0 works
- 5 Periodontal Regeneration and Treatments Urology 0 works
- 6 Biomedical Ethics and Regulation Physiology 0 works
- 7 Polish Law and Legal System Political Science and International Relations 0 works
- 8 Acute Myocardial Infarction Research Cardiology and Cardiovascular Medicine 0 works
- 9 Biosimilars and Bioanalytical Methods Immunology 0 works
- 10 Polish Legal and Social Issues Law 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Credo Reference (United States)'s research output changed?
Output in 2018–2022 was 67% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Boston
- Boston University
- Massachusetts General Hospital
- Brigham and Women's Hospital
- Northeastern University
- Boston Children's Hospital
- Boston College
- Beth Israel Deaconess Medical Center
- General Electric (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.